|
|
 |
|
Viewing report
|
|
|
|
Carotid Stent Systems Market Current Status & Future Outlook
Medtech Reports, June 2011, Pages: 35
The world market for carotid stent systems, which was valued at $150 million in 2010, is expected to double by 2015.
Despite the fact that carotid stents were available in Europe since 2000, and with over a decade of clinical experience with carotid stenting as an alternative to surgery, the market is still in its early stages of development.
Carotid artery stents were approved by the FDA in 2004 for high surgical risk patients and the first procedure specific carotid stent was approved in Japan in 2008.
The market for carotid stent systems serves primarily older people with progressive atherosclerotic disease, so based on demographics alone demand for a minimally invasive catheter-based treatment option should continue to grow.
Recent results from the CREST trial coupled with extending indication, by the FDA, to include standard-risk surgery patients will propel growth.
Abbott Vascular, Cordis, Boston Scientific, Medtronic and Covidien have transformed the competitive landscape of the market by bundling their carotid stents with their embolic protection devices as complete Carotid Stent Systems.
However, the competitive landscape is about to experience further change as companies in the neurovascular space embrace the technology in an effort to broaden their offering to their client base with comprehensive stroke management solutions.
This should open windows of opportunities for innovative stents and embolic filters design and development companies to license their technologies and spin off their in-development products.
Carotid Stent Systems Market - Current Status & Future Outlook report offers an overview of the state of both the technology and the market. It profiles current market landscape for carotid stent systems and explores market potential for the devices with global forecast to 2015.
Report Highlights:
- Current State of the Science for both carotid endarterectomy (CEA) and carotid angioplasty and stenting (CAS).
- Recent clinical trials and their findings.
- Epidemiology of stroke, transient ischemic attacks (TIAs), carotid stenosis and estimated number of carotid artery stenting procedures.
- Current market for carotid stent systems segmented geographically.
- Potential market for cartoid stent systems.
- Leading players in the cartotid stent systems space.
- Market forecast to 2015
|
|
|
|
